Become a Member

Discussions

written by reader Marc Chaikin –The Number One Stock to buy now

Does anyone know what he is promoting? I’m giving away the ticker symbol of the #1 stock to buy now… using the same system that bears my name on every Bloomberg terminal on Wall Street But today, I’m going public with something I’ve never said on national air… not in any of my appearances on […]

written by reader Weiss Issues “Buy” on AI Sleeper

Weiss Ratings has issued a “Buy” on a stock that’s leading the AI revolution in one of the most profitable industries in the world. I share the details in my just-released special briefing, “The Next AI Bonanza.” Martin D. Weiss, PhD, investorinteldaily.com

written by reader Green Chip Stocks EN-23 Trillion Dollar Pill

Which company? This is not Ozempic, Advil, or vitamin D… It’s an entirely new class of medicine that could earn you an absolute FORTUNE. Because not only can it make you smarter, make you stronger, and extend your life span by as much as 20 years… It’s also the most profitable drug in human history… […]

written by reader Luke Lango’s 2nd Trillion Dollar AI Trade 3//27/24

Gonna keep this one short because after 55 minutes of hype, in my opinion this is just his answer to Joel Litman’s program announced yesterday — each one has their five or 6 biotech stocks poised to have thousand percent gains. Lango’ s program is HIGH VELOCITY STOCKS, same list price 5000, lower ‘today’ price […]


Jinxed says:
His free picks have been less than stellar, so I hesitate to purchase his portfolio.

Jinxed says:
He mentioned un-named drug #INS018_055 . A quick Google search indicates it belongs to Insilico Medicine, but it's not available…

written by reader Litman / Stansberry presentation – historic market anomoly – MICROCAP CONFIDENTIAL (March 26, 2024)

Porter STansberry and Joel Litman presented on March 26. The theme of the presentation was “Historic Market Anomaly, 1 in 20 year money making opportunity.” But it evolved into their taking about Biotech stocks and how some of them are trading for less than the cash value of the company, calling them Net-Net companies. They […]


Raúl says:
Use your $2500 to buy the XBI if you want biotech exposure during the upcoming rate cuts.

written by reader Professor Littman, Microcap Confidential

I just listened to the program “Urgent Stock Market Update with Porter Stansberry and Prof. Littman about net net biotech stocks due to raised interest rates. I would be interested in hearing Travis’ thoughts on the 5 Best Negative EV Biotech Opportunities in 2024 and any other comments. Thank you. Macrame Momma

Thursday File: A Buy and a Sell before Good Friday

Getting this out a bit early because everything’s closed up for the Good Friday holiday tomorrow. What’s up with the Real Money Portfolio? We did get a few final 2023 reports… and that led to some investment decisions on my part. The Boston Omaha (BOC) annual report came in a little later than last year, […]

Sorry about that. I bumped it up by about 15%

Natorious says:
For BOC at these prices the optionality on SKYH could indeed be quite good. Hard to imagine SKHY doing well…

What’s Lashmet’s “Hunger Switch” Stock?

We’ve seen tons of stories about GLP-1 drugs, and have watched the big sellers of those drugs, Novo Nordisk (NVO) and Eli Lilly (LLY), become by far the largest pharma companies in the world (Lilly, in particular, has touched a $750 billion valuation… closing in on the “Magnificent Seven” tech stocks and breaking into the […]


Hugh108 says:
Another cure for obesity is to come to Japan and live here for a long time and eat Japanese food…

doc5653 says:
I'm no fan of these drugs, which seem to be "evergreen " treatments (you need to take them forever). Nonetheless…

“EN-23: The Real-Life Limitless Pill?” Looking into Jeff Siegel’s latest Green Chip Stocks teaser

The world of psychedelics was briefly exciting for investors, mostly back around 2019-2020 or so, when everyone was looking for the next version of the cannabis bull market (remember that?)… and as potential for legalization of some drugs, like psilocybin (“magic mushrooms”), seemed to be in the wind, and old hallucinogenic or psychedelic compounds were […]


durangorandy says:
I jumped on CMPS as a purely speculative move and hung with it as it dropped and then rebounded. I…
I'm recommending Compass Pathways (CMPS) in Biotech Moonshots for their proprietary psilocybin drug for treatment-resistant depression. Very successful in Phase…

written by reader Nexo Crypto – teeka Palm beach

Few years ago they recommended getting out from Nexo… this was after Celsius, SBF, etc. I see Nexo is still alive and couldn’t find anything that could suggest a collapse. I once read here that someone considered Nexo as a Suisse Bank comparatively speaking. Does anybody know if Palm Beach, or others, recommend staying away […]


Jinxed says:
NEXO is not a current recommendation in any of the Palm Beach portfolios.

written by reader 75 Billion $ patent Anyone familiar with this recent pitch by Future Retirement Success?

Tiny biotech wins 75 billion dollar patent. On March 1, 2022, a tiny biotech firm won a patent on a new treatment that can “Cut & Paste” disease from your body. The Wall Street Journal reports this company is “transforming medicine.”


Travis Johnson, Stock Gumshoe says:
That sounds like yet another repeat of the Dylan Jovine/Behind the Markets tease of Editas, an ad we've been seeing…

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info